Mehmet Hanifi Yalçın
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Hanifi Yalçın has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Suleyman Aydin
Department of Medical Biochemistry, Faculty of Medicine, Fırat University, 23119 Elazığ, Türkiye
4 shared publications - Taner Akbulut
Faculty of Sport Sciences, Fırat University, Elazığ, Turkey
4 shared publications - Vedat Çınar
Faculty of Sport Science, Fırat University, Elazig 23119, Türkiye
4 shared publications - Yavuz Yasul
Bafra Vocational School, Ondokuz Mayıs University, 55400 Samsun, Türkiye
4 shared publications - Berrin Tarakçi Gençer
Department of Histology Embryology, Faculty of Veterinary Medicine, Firat University, 23100 Elazig, Türkiye
2 shared publications - Faruk Akçınar
Department of Coaching Education, Faculty Sport Science, Inonu University, Malatya 44000, Türkiye
2 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 899
Tissue-Specific Myonectin and Endocan Responses to Exercise Intensity and Coenzyme Q10 Supplementation in Rats
Objective: This study aimed to evaluate the effects of different exercise intensities combined with CoQ10 supplementation on hepatic and renal myonectin and endocan levels and immunoreactivity, as well as glucose–insulin responses. Methods: The study was conducted using a randomized, post-test-controlled experimental design. Forty-eight male Wistar Albino rats were divided into six groups (n = 8): control (C), low-intensity exercise (LIE), high-intensity exercise (HIE), CoQ10 supplementation (Supp), LIE plus supplementation (LIESupp), and HIE plus supplementation (HIESupp). Exercise protocols were performed 5 days per week for 6 weeks, and CoQ10 was administered by oral gavage at a dose of 5 mg/kg/day. Hepatic and renal myonectin and endocan levels were measured using ELISA, tissue immunoreactivity was assessed by immunohistochemistry, and glucose and insulin levels were analyzed biochemically. Results: Compared with the C group, glucose and insulin levels were higher in the Supp group, whereas glucose levels were lower in the LIESupp group (p < 0.001). Hepatic myonectin levels were higher in the LIE group than in the C group (p < 0.001), whereas renal myonectin levels were lower in the HIESupp group (p = 0.006). Renal endocan levels were higher in the LIESupp group than in the C group (p < 0.001), while hepatic endocan levels were higher in the Supp and LIESupp groups (p < 0.001). Compared with the C group, myonectin immunoreactivity was higher in both the liver and kidney in the LIE group (p = 0.001 and p = 0.006, respectively), whereas renal endocan immunoreactivity was higher in the LIESupp group (p = 0.016). These findings also showed condition-dependent exercise × CoQ10 interactions. Conclusions: The findings indicate that glucose–insulin, myonectin, and endocan responses to low- and high-intensity exercise combined with CoQ10 supplementation are not unidirectional and that differences at the biochemical and tissue levels vary according to exercise intensity.
- 17 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 899
Open AccessTissue-Specific Myonectin and Endocan Responses to Exercise Intensity and Coenzyme Q10 Supplementation in Rats
Objective: This study aimed to evaluate the effects of different exercise intensities combined with CoQ10 supplementation on hepatic and renal myonectin and endocan levels and immunoreactivity, as well as glucose–insulin responses. Methods: The study was conducted using a randomized, post-test-controlled experimental design. Forty-eight male Wistar Albino rats were divided into six groups (n = 8): control (C), low-intensity exercise (LIE), high-intensity exercise (HIE), CoQ10 supplementation (Supp), LIE plus supplementation (LIESupp), and HIE plus supplementation (HIESupp). Exercise protocols were performed 5 days per week for 6 weeks, and CoQ10 was administered by oral gavage at a dose of 5 mg/kg/day. Hepatic and renal myonectin and endocan levels were measured using ELISA, tissue immunoreactivity was assessed by immunohistochemistry, and glucose and insulin levels were analyzed biochemically. Results: Compared with the C group, glucose and insulin levels were higher in the Supp group, whereas glucose levels were lower in the LIESupp group (p < 0.001). Hepatic myonectin levels were higher in the LIE group than in the C group (p < 0.001), whereas renal myonectin levels were lower in the HIESupp group (p = 0.006). Renal endocan levels were higher in the LIESupp group than in the C group (p < 0.001), while hepatic endocan levels were higher in the Supp and LIESupp groups (p < 0.001). Compared with the C group, myonectin immunoreactivity was higher in both the liver and kidney in the LIE group (p = 0.001 and p = 0.006, respectively), whereas renal endocan immunoreactivity was higher in the LIESupp group (p = 0.016). These findings also showed condition-dependent exercise × CoQ10 interactions. Conclusions: The findings indicate that glucose–insulin, myonectin, and endocan responses to low- and high-intensity exercise combined with CoQ10 supplementation are not unidirectional and that differences at the biochemical and tissue levels vary according to exercise intensity.
- Open Access
- 22 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2853
Exercise and Carnosine Modulate Microbiota-Derived Metabolites, Myokines, and Cardiometabolic Profiles in Rats: A Randomized Controlled Trial
Background/Objectives: Carnosine and exercise independently improve metabolic health, yet their combined effects on myokines and microbiota-derived metabolites remain underexplored. This study evaluated the synergistic impact of carnosine supplementation and exercise intensity on microbiota-derived metabolites, as well as skeletal muscle and myocardial expression of irisin and myonectin, focusing on lipid and glycemic regulation. Methods: A randomized post-test control study was conducted using 49 male Sprague Dawley rats (9 weeks old; 250.39 ± 1.85 g), divided into 7 groups: control (C), sham (S), moderate-intensity continuous training (MICT), high-intensity continuous training (HICT), carnosine (CA), MICT with carnosine (MICTCA), and HICT with carnosine (HICTCA). Interventions included treadmill-based moderate or high-intensity training and carnosine supplementation (100 mg/kg/day) for 5 weeks. Blood samples were collected post-decapitation; plasma was analyzed for lipid profile, glycemic parameters, and microbiota-derived metabolites using enzymatic and ELISA methods. Irisin and myonectin levels were assessed in plasma and myocardial and skeletal muscle tissues via ELISA and immunohistochemistry. Results: The HICTCA group showed the lowest body weight, highest HDL-C, and lowest LDL-C, TC, TG, and atherogenic index. Irisin and myonectin levels in skeletal muscle and myocardium were also highest in HICTCA. The trimethylamine N-oxide (TMAO) was lowest and S-equol highest in HICTCA, whereas indoxyl sulfate (IS) peaked in HICT and was lowest in the C group. Principal component analysis revealed strong positive associations between HICTCA and cardiometabolic biomarkers. Conclusions: High-intensity training combined with carnosine may reduce weight gain, improve lipid and glycemic profiles, and enhance myokines and microbiota-derived metabolites.
- 22 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2853
Open AccessExercise and Carnosine Modulate Microbiota-Derived Metabolites, Myokines, and Cardiometabolic Profiles in Rats: A Randomized Controlled Trial
Background/Objectives: Carnosine and exercise independently improve metabolic health, yet their combined effects on myokines and microbiota-derived metabolites remain underexplored. This study evaluated the synergistic impact of carnosine supplementation and exercise intensity on microbiota-derived metabolites, as well as skeletal muscle and myocardial expression of irisin and myonectin, focusing on lipid and glycemic regulation. Methods: A randomized post-test control study was conducted using 49 male Sprague Dawley rats (9 weeks old; 250.39 ± 1.85 g), divided into 7 groups: control (C), sham (S), moderate-intensity continuous training (MICT), high-intensity continuous training (HICT), carnosine (CA), MICT with carnosine (MICTCA), and HICT with carnosine (HICTCA). Interventions included treadmill-based moderate or high-intensity training and carnosine supplementation (100 mg/kg/day) for 5 weeks. Blood samples were collected post-decapitation; plasma was analyzed for lipid profile, glycemic parameters, and microbiota-derived metabolites using enzymatic and ELISA methods. Irisin and myonectin levels were assessed in plasma and myocardial and skeletal muscle tissues via ELISA and immunohistochemistry. Results: The HICTCA group showed the lowest body weight, highest HDL-C, and lowest LDL-C, TC, TG, and atherogenic index. Irisin and myonectin levels in skeletal muscle and myocardium were also highest in HICTCA. The trimethylamine N-oxide (TMAO) was lowest and S-equol highest in HICTCA, whereas indoxyl sulfate (IS) peaked in HICT and was lowest in the C group. Principal component analysis revealed strong positive associations between HICTCA and cardiometabolic biomarkers. Conclusions: High-intensity training combined with carnosine may reduce weight gain, improve lipid and glycemic profiles, and enhance myokines and microbiota-derived metabolites.
- Open Access
- 10 August 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (16) , 8828
Tissue-Specific Modulation of Spexin Expression in Diet-Induced Obese Male Rats: Comparative Effects of Aerobic Exercise and Metformin
Obesity, a major global health concern, is associated with systemic metabolic dysregulation. Spexin, a peptide implicated in appetite control and energy balance, may represent a biomarker and therapeutic target in obesity management. This study aimed to investigate tissue-specific modulation of spexin expression in obese male rats subjected to aerobic exercise and/or metformin treatment. Thirty-six Sprague–Dawley rats were randomly assigned to six groups (n = 6 per group): (i) control, (ii) obese control, (iii) exercise, (iv) metformin, (v) metformin + exercise, and (vi) a decapitation baseline group. Obesity was induced via a 12-week high-calorie diet. Subsequently, interventions were applied over 4 weeks: treadmill running (30 min/day, 5 days/week) and/or metformin (150 mg/kg/day). Post-intervention, body weight significantly decreased in intervention groups (p < 0.001) exercise (−13.7%), metformin (−14.6%), and metformin + exercise (−21.1%) compared to the obese control group. ELISA revealed tissue-specific effects on spexin expression. In skeletal muscle, spexin levels were highest in controls (628 ± 160.5 pg/mL), with a significant reduction in the metformin + exercise group (349 ± 84.7 pg/mL; p = 0.003, Cohen’s d = 2.17). In the liver, the control group showed the highest expression (443 ± 240.8 pg/mL), while metformin + exercise yielded the lowest (254 ± 20.4 pg/mL). In contrast, heart tissue maintained elevated spexin levels across all intervention groups, with the metformin + exercise group nearly matching control levels (617 ± 25.2 vs. 618 ± 53.2 pg/mL). Immunohistochemistry confirmed these patterns, with the highest cardiac histoscore in the metformin + exercise group (2.34 ± 0.09). Hierarchical clustering underscored distinct tissue-specific expression patterns, separating muscle from liver and heart. Collectively, these findings suggest that spexin is differentially regulated by exercise and metformin, with joint effects and complex, tissue-specific modulation. This highlights spexin’s potential as a biomarker and therapeutic target in precision obesity interventions.
- 10 August 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (16) , 8828
Open AccessTissue-Specific Modulation of Spexin Expression in Diet-Induced Obese Male Rats: Comparative Effects of Aerobic Exercise and Metformin
Obesity, a major global health concern, is associated with systemic metabolic dysregulation. Spexin, a peptide implicated in appetite control and energy balance, may represent a biomarker and therapeutic target in obesity management. This study aimed to investigate tissue-specific modulation of spexin expression in obese male rats subjected to aerobic exercise and/or metformin treatment. Thirty-six Sprague–Dawley rats were randomly assigned to six groups (n = 6 per group): (i) control, (ii) obese control, (iii) exercise, (iv) metformin, (v) metformin + exercise, and (vi) a decapitation baseline group. Obesity was induced via a 12-week high-calorie diet. Subsequently, interventions were applied over 4 weeks: treadmill running (30 min/day, 5 days/week) and/or metformin (150 mg/kg/day). Post-intervention, body weight significantly decreased in intervention groups (p < 0.001) exercise (−13.7%), metformin (−14.6%), and metformin + exercise (−21.1%) compared to the obese control group. ELISA revealed tissue-specific effects on spexin expression. In skeletal muscle, spexin levels were highest in controls (628 ± 160.5 pg/mL), with a significant reduction in the metformin + exercise group (349 ± 84.7 pg/mL; p = 0.003, Cohen’s d = 2.17). In the liver, the control group showed the highest expression (443 ± 240.8 pg/mL), while metformin + exercise yielded the lowest (254 ± 20.4 pg/mL). In contrast, heart tissue maintained elevated spexin levels across all intervention groups, with the metformin + exercise group nearly matching control levels (617 ± 25.2 vs. 618 ± 53.2 pg/mL). Immunohistochemistry confirmed these patterns, with the highest cardiac histoscore in the metformin + exercise group (2.34 ± 0.09). Hierarchical clustering underscored distinct tissue-specific expression patterns, separating muscle from liver and heart. Collectively, these findings suggest that spexin is differentially regulated by exercise and metformin, with joint effects and complex, tissue-specific modulation. This highlights spexin’s potential as a biomarker and therapeutic target in precision obesity interventions.
- Open Access
- 28 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (5) , 2618
Moderate/High-Intensity Exercise and Coenzyme Q10 Supplementation May Reduce Tumstatin and Improve the Lipid Dynamics and Body Mass in Rats
Coenzyme Q10 (CoQ10) is a molecule that serves as a coenzyme for mitochondrial enzymes, playing a fundamental role in mitochondrial bioenergetics as an electron and proton carrier in the energy production process. This study aimed to examine the modulatory effects of moderate/high-intensity exercise and CoQ10 supplementation on tumstatin, lipid dynamics, and body mass in rats. This study used 42 male Wistar Albino rats in six groups: a control group (C), a moderate-intensity continuous training group (MICT), a high-intensity continuous training group (HICT), a coenzyme Q10 group (Q10), a moderate-intensity continuous training combined with Q10 group (MICTQ10), and a high-intensity continuous training combined with Q10 group (HICTQ10) to assess the effects of exercise and 5 mg/kg/daily CoQ10 supplementation. Rats underwent treadmill training, and tumstatin levels in plasma, cardiac, and skeletal muscle tissues were measured using ELISA and immunostaining techniques. In addition to the plasma, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC) levels were analyzed using enzymatic methods, with the LDL-C calculated using the Friedewald equation. The atherogenic index of plasma was determined by the TG/HDL-C ratio. As compared to group C, body mass was significantly affected by both exercise intensity and supplementation (p = 0.01, η2 = 0.37), with the MICTQ10 and HICTQ10 groups demonstrating the greatest reductions by day 50th (p = 0.0003, d = 4.02; p = 0.0001, d = 3.99). Lipid profiles varied significantly between groups. Compared to the C group, the MICTQ10 group exhibited the most substantial decreases in LDL-C (p = 0.03, d = 2.35) and TG levels (p = 0.03, d = 2.25), while the HICTQ10 group showed the most pronounced reduction in TC levels (p = 0.001, d = 6.41). Regarding tumstatin levels, skeletal muscle tumstatin levels were lowest in the HICTQ10 group (p = 0.01, d = 2.11). Moreover, cardiac muscle tumstatin levels were significantly lower in the MICTQ10, MICT, and HICTQ10 groups compared to in the C group (p = 0.004, d = 1.01). These findings suggest that both exercise intensity and CoQ10 supplementation exert notable physiological effects, particularly in modulating body mass, lipid metabolism, and tumstatin levels.
- 28 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (5) , 2618
Open AccessModerate/High-Intensity Exercise and Coenzyme Q10 Supplementation May Reduce Tumstatin and Improve the Lipid Dynamics and Body Mass in Rats
Coenzyme Q10 (CoQ10) is a molecule that serves as a coenzyme for mitochondrial enzymes, playing a fundamental role in mitochondrial bioenergetics as an electron and proton carrier in the energy production process. This study aimed to examine the modulatory effects of moderate/high-intensity exercise and CoQ10 supplementation on tumstatin, lipid dynamics, and body mass in rats. This study used 42 male Wistar Albino rats in six groups: a control group (C), a moderate-intensity continuous training group (MICT), a high-intensity continuous training group (HICT), a coenzyme Q10 group (Q10), a moderate-intensity continuous training combined with Q10 group (MICTQ10), and a high-intensity continuous training combined with Q10 group (HICTQ10) to assess the effects of exercise and 5 mg/kg/daily CoQ10 supplementation. Rats underwent treadmill training, and tumstatin levels in plasma, cardiac, and skeletal muscle tissues were measured using ELISA and immunostaining techniques. In addition to the plasma, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC) levels were analyzed using enzymatic methods, with the LDL-C calculated using the Friedewald equation. The atherogenic index of plasma was determined by the TG/HDL-C ratio. As compared to group C, body mass was significantly affected by both exercise intensity and supplementation (p = 0.01, η2 = 0.37), with the MICTQ10 and HICTQ10 groups demonstrating the greatest reductions by day 50th (p = 0.0003, d = 4.02; p = 0.0001, d = 3.99). Lipid profiles varied significantly between groups. Compared to the C group, the MICTQ10 group exhibited the most substantial decreases in LDL-C (p = 0.03, d = 2.35) and TG levels (p = 0.03, d = 2.25), while the HICTQ10 group showed the most pronounced reduction in TC levels (p = 0.001, d = 6.41). Regarding tumstatin levels, skeletal muscle tumstatin levels were lowest in the HICTQ10 group (p = 0.01, d = 2.11). Moreover, cardiac muscle tumstatin levels were significantly lower in the MICTQ10, MICT, and HICTQ10 groups compared to in the C group (p = 0.004, d = 1.01). These findings suggest that both exercise intensity and CoQ10 supplementation exert notable physiological effects, particularly in modulating body mass, lipid metabolism, and tumstatin levels.
- Open Access
- 30 January 2024
- Published by Springer Nature in Research Square
Investigation of the Effects of Silymarin and Vitamin C on Kidney Damage and Aquaporin-2 Downregulation in Lithium-Induced Nephrogenic Diabetes Insipidus in Rats
While lithium (LIT) therapy is widely regarded as the primary approach for managing bipolar disorder over the long term, it is also a major contributor to the development of acquired Nephrogenic Diabetes Insipidus (NDI) with prolonged use. This study aimed to examine the protective effects of Silymarin, Vitamin C, and the combined administration of SIL + Vit C against nephrotoxicity induced by NDI resulting from long-term LIT treatment in rats. The groups of rats exposed to LIT were provided with 1 kg of regular commercial chow containing an 80 mmol LiCl supplement for 28 days. Meanwhile, SIL and Vit C were orally administered to rats at a dosage of 200 and 100 mg/kg body weight, respectively, throughout the 28 days. Both the levels of reactive oxygen species (ROS) glutathione (GSH) and malondialdehyde (MDA) were assessed and enzyme activities of superoxide dismutase (SOD) were assessed to determine the protective effect of SIL and Vit C against oxidative stress. Aquaporin-2 (AQP2) levels in kidney tissues were evaluated immunohistochemically and by ELISA method to determine the anti-downregulatory effect. In addition, serum and urine parameters were measured. Lithium-induced nephrotoxicity was characterized by elevated levels of renal toxicity markers and reduced antioxidant enzyme activities. Administration of SIL significantly reduced kidney tissue toxicity markers, increased antioxidant enzyme activities, regulation of physiological parameters in blood and urine, and downregulation of AQP2 in the kidney. However, no significant protective effect against lithium-induced renal toxicity was observed with the administration of Vitamin C. These findings indicate that SIL effectively guards against lithium-induced nephrotoxicity, whereas Vitamin C does not possess this protective effect.
- 30 January 2024
- Published by Springer Nature in Research Square
Open AccessInvestigation of the Effects of Silymarin and Vitamin C on Kidney Damage and Aquaporin-2 Downregulation in Lithium-Induced Nephrogenic Diabetes Insipidus in Rats
While lithium (LIT) therapy is widely regarded as the primary approach for managing bipolar disorder over the long term, it is also a major contributor to the development of acquired Nephrogenic Diabetes Insipidus (NDI) with prolonged use. This study aimed to examine the protective effects of Silymarin, Vitamin C, and the combined administration of SIL + Vit C against nephrotoxicity induced by NDI resulting from long-term LIT treatment in rats. The groups of rats exposed to LIT were provided with 1 kg of regular commercial chow containing an 80 mmol LiCl supplement for 28 days. Meanwhile, SIL and Vit C were orally administered to rats at a dosage of 200 and 100 mg/kg body weight, respectively, throughout the 28 days. Both the levels of reactive oxygen species (ROS) glutathione (GSH) and malondialdehyde (MDA) were assessed and enzyme activities of superoxide dismutase (SOD) were assessed to determine the protective effect of SIL and Vit C against oxidative stress. Aquaporin-2 (AQP2) levels in kidney tissues were evaluated immunohistochemically and by ELISA method to determine the anti-downregulatory effect. In addition, serum and urine parameters were measured. Lithium-induced nephrotoxicity was characterized by elevated levels of renal toxicity markers and reduced antioxidant enzyme activities. Administration of SIL significantly reduced kidney tissue toxicity markers, increased antioxidant enzyme activities, regulation of physiological parameters in blood and urine, and downregulation of AQP2 in the kidney. However, no significant protective effect against lithium-induced renal toxicity was observed with the administration of Vitamin C. These findings indicate that SIL effectively guards against lithium-induced nephrotoxicity, whereas Vitamin C does not possess this protective effect.